1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate,
2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate,
2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate,
Actonel,
Atelvia,
Bisphosphonate Risedronate Sodium,
risedronate,
risedronate sodium,
Risedronate Sodium, Bisphosphonate,
risedronic acid,
risedronic acid, monosodium salt,
Sodium, Bisphosphonate Risedronate,
Risedronate sodium,
Sodium risedronate,
115436-72-1,
Actonel,
UNII-OFG5EXG60L,
NE 58095,
OFG5EXG60L,
Risedronic acid monosodium salt,
Monosodium (1-hydroxy-2-(3-pyridinyl)ethylidene)bisphosphonate,
Sodium trihydrogen (1-hydroxy-2-(3-pyridyl)ethylidene)diphosphonate,
Actonel (TN),
C7H10NNaO7P2,
Q-201723,
Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-, monosodium salt,
MFCD00867080,
Risedronate sodium [USAN],
Risedronic acid sodium salt,
C7H10NO7P2.Na,
Optinate,
RISEDRONIC ACID SODIUM,
Acrel,
Risedronate sodium [USAN:USP],
Optinate Septimum,
Risedronate-sodium,
Monosodium Risedronate,
Risedronate sodium salt,
NE 58095 Sodium,
Risedronate sodium (USP),
AC1Q1VB7,
CHEMBL1654,
SCHEMBL18377,
Risedronate sodium, min 97%,
AC1N5G27,
CHEBI:8868,
risedronic acid, monosodium salt,
CTK8F0842,
DRFDPXKCEWYIAW-UHFFFAOYSA-M,
ACT03362,
AC-732,
CS0033,
MFCD01706268,
s1428,
AKOS015833432,
AB09807,
API0004080,
CCG-213235,
RTC-070962,
NCGC00346521-01,
AC-20120,
AN-15580,
AS-13309,
CPD000469279,
H864,
SAM001246537,
AB2000101,
LS-106650,
TC-070962,
FT-0631078,
M2289,
D00942,
J10129,
K-1095,
AB01274790-01,
I02-0324,
2-(3-Pyridinyl)-2-hydroxyethylidene-1,1-bisphosphonate,
Monosodium 1-Hydroxy-2-(3-pyridyl)ethylidene-1,1-diphosphonate,
[1-Hydroxy-2-(3-pyridinyl)ethylidene]bisphosphonic Acid Monosodium Salt,
1-hydroxy-2-(3-pyridinyl) ethylidene bis-phosphonic acid monosodium salt,
Hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate (Na+),
P,P'-[1-Hydroxy-2-(3-pyridonyl)ethylidene]bis-phosphonic acid sodium salt,
Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-, disodium salt,
Phosphonic acid, (2-hydroxy-2-(3-pyridinyl)ethylidene)bis-, disodium salt,
Risedronate sodium, United States Pharmacopeia (USP) Reference Standard,
sodium hydrogen (1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl)phosphonate,
sodium hydrogen(1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl)phosphonate,
sodium hydrogen-1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethylphosphonate,
sodium hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate,
sodium hydroxy-[1-hydroxy-1-phosphono-2-(3-pyridyl)ethyl]phosphinate,
1-hydroxy-1-[hydroxy(sodiooxy)phosphoryl]-2-(pyridin-3-yl)ethylphosphonic acid,
Phosphonic acid, P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-, sodium salt (1:1),
Risedronate sodium 2.5-hydrate, European Pharmacopoeia (EP) Reference Standard,
Risedronate Sodium, Pharmaceutical Secondary Standard; Certified Reference Material,
122458-82-6,
934544-85-1,
Risedronate,
Atelvia,
Benet,
Risedronate (sodium),
C7-H10-N-O7-P2.Na,
NE-58095,
CID68739,
RISEDRONIC ACID, SODIUM SALT,
AR-1L3123,
CID4194514,
CS-O-30749,
Risedronate sodium, 98% - 250MG 250mg,
(1-hydroxy-2-(3-pyridinyl)ethylidene)-bis(phosphonic acid) monosodium salt,
124428-38-2,
329003-65-8,